when FDA reviewers rush to approve a drug on deadline are 4-5 times more likely to be withdrawn or require serious safety warnings

i don’t think i need to comment about this one! is it any surprise that understaffed FDA  approvals that are rushed to meet the deadline are more likely to be unsafe when they reach the public?
from fiercepharma newsletter:
When FDA reviewers cram, do they perform poorly on the test? A new study concludes that yes, when [...]

Read Full Post »

FDA claims science rather than politics or pricing is behind the growing difficulties facing new pharmaceuticals attempting to reach the market.

this is from “the financial times” via the newsletter from “fiercebiotech”. it is just interesting to read this article comming from the FDA to pharma execs…politics and pricing have nothing to do with difficulties…the fault lies with science? do you believe that?
“Pharma is having a difficult time but we are seeing drugs that have a [...]

Read Full Post »

“Consumers’ Right to Sue Weakening: Upcoming Case Could Bar Public From Taking Drug Makers to Court”

taking away the right to sue drug companies…big pharma must be leaning back, laughing and holding its fat belly!
from the washington independant 3/24/08:
“But throughout the history of the Food and Drug Administration, and its precursor agencies, U.S. consumers could always bring the manufacturer of a faulty product to court. Now, with the FDA woefully underfunded [...]

Read Full Post »